For more than 30 years Fosfestrol (Honvan®) has been used as an estrogen for successful palliative therapy of prostatic carcinoma, but the pharmacokinetics of this compound were unknown due to the lack of analytical methods. Over the last few years we have developed a special extraction process for Fosfestrol and its metabolites from plasma with recovery yields > 90%. The simultaneous measurement of the most important compounds after intravenous and oral administration was achieved by high-performance liquid chromatography, either with the UV detector (236 nm) or with an electrochemical detector (+ 1 V). The working electrode is a carbon paste electrode constructed in this laboratory; the counter electrode is an Au and the reference electrode an Ag/AgCl electrode. The electrode processes have been clarified. Fosfestrol and its monophosphate exist only for a short time in small amounts in the circulating blood after intravenous administration, whilst after oral administration, not even traces of the phosphates could be detected in the plasma. The most important influence on plasma levels of Fosfestrol and its metabolites is due to the extraction function of the liver. Diethylstilbestrol conjugates enter into the enterohepatic circle, thus forming a possible source of DES available over more than 24 h. Only DES glucuronide and DES glucuronide-sulphate are renally eliminated and could be detected after administration over 3 days.

Keywords:
Fosfestrol, pharmacokinetics, Prostatic carcinoma, Electrodes
This content is only available via PDF.
© 1988 S. Karger AG, Basel
1988
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.